Smead Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $246M | Sell |
697,919
-103,877
| -13% | -$37M | 5.34% | 5 |
|
|
2025
Q4 | $262M | Sell |
801,796
-55,588
| -6% | -$17.6M | 5.45% | 5 |
|
|
2025
Q3 | $242M | Sell |
857,384
-65,584
| -7% | -$19M | 4.67% | 9 |
|
|
2025
Q2 | $258M | Sell |
922,968
-123,046
| -12% | -$34.9M | 5.16% | 5 |
|
|
2025
Q1 | $326M | Sell |
1,046,014
-99,042
| -9% | -$29.2M | 5.59% | 3 |
|
|
2024
Q4 | $298M | Sell |
1,145,056
-27,810
| -2% | -$8.25M | 4.63% | 8 |
|
|
2024
Q3 | $378M | Buy |
1,172,866
+39,559
| +3% | +$12.9M | 5.39% | 6 |
|
|
2024
Q2 | $354M | Buy |
1,133,307
+59,456
| +6% | +$17.5M | 5.53% | 6 |
|
|
2024
Q1 | $305M | Buy |
1,073,851
+44,083
| +4% | +$12.9M | 4.76% | 8 |
|
|
2023
Q4 | $297M | Sell |
1,029,768
-80,556
| -7% | -$21.9M | 5.31% | 8 |
|
|
2023
Q3 | $298M | Sell |
1,110,324
-38,229
| -3% | -$9.54M | 6.09% | 5 |
|
|
2023
Q2 | $255M | Sell |
1,148,553
-13,398
| -1% | -$3.11M | 5.06% | 8 |
|
|
2023
Q1 | $281M | Buy |
1,161,951
+19,747
| +2% | +$4.85M | 5.6% | 7 |
|
|
2022
Q4 | $300M | Buy |
1,142,204
+97,915
| +9% | +$26.2M | 6.42% | 3 |
|
|
2022
Q3 | $235M | Buy |
1,044,289
+16,586
| +2% | +$4.02M | 6.12% | 3 |
|
|
2022
Q2 | $250M | Buy |
1,027,703
+61,712
| +6% | +$15.1M | 6.39% | 3 |
|
|
2022
Q1 | $234M | Buy |
965,991
+150,001
| +18% | +$34.5M | 5.42% | 4 |
|
|
2021
Q4 | $184M | Buy |
815,990
+210,890
| +35% | +$44.5M | 4.77% | 8 |
|
|
2021
Q3 | $129M | Buy |
605,100
+79,468
| +15% | +$18.3M | 4.4% | 12 |
|
|
2021
Q2 | $128M | Buy |
525,632
+61,010
| +13% | +$15M | 4.49% | 9 |
|
|
2021
Q1 | $116M | Buy |
464,622
+71,336
| +18% | +$17M | 5.09% | 5 |
|
|
2020
Q4 | $90.4M | Sell |
393,286
-15,020
| -4% | -$3.46M | 5.23% | 6 |
|
|
2020
Q3 | $104M | Sell |
408,306
-44,186
| -10% | -$10.9M | 6.57% | 4 |
|
|
2020
Q2 | $107M | Sell |
452,492
-78,139
| -15% | -$17.8M | 6.73% | 3 |
|
|
2020
Q1 | $108M | Sell |
530,631
-103,508
| -16% | -$22.6M | 7.63% | 1 |
|
|
2019
Q4 | $153M | Buy |
634,139
+5,753
| +0.9% | +$1.27M | 6.8% | 3 |
|
|
2019
Q3 | $122M | Sell |
628,386
-17,713
| -3% | -$3.4M | 5.94% | 4 |
|
|
2019
Q2 | $119M | Sell |
646,099
-20,666
| -3% | -$3.7M | 5.73% | 4 |
|
|
2019
Q1 | $127M | Sell |
666,765
-15,210
| -2% | -$2.9M | 6.43% | 2 |
|
|
2018
Q4 | $133M | Sell |
681,975
-29,682
| -4% | -$5.79M | 6.94% | 1 |
|
|
2018
Q3 | $148M | Sell |
711,657
-17,812
| -2% | -$3.51M | 6.66% | 2 |
|
|
2018
Q2 | $135M | Sell |
729,469
-13,089
| -2% | -$2.32M | 6.41% | 2 |
|
|
2018
Q1 | $127M | Buy |
742,558
+60,444
| +9% | +$11.1M | 6.13% | 2 |
|
|
2017
Q4 | $119M | Sell |
682,114
-30,788
| -4% | -$5.45M | 5.4% | 6 |
|
|
2017
Q3 | $133M | Sell |
712,902
-9,547
| -1% | -$1.69M | 6.33% | 2 |
|
|
2017
Q2 | $124M | Sell |
722,449
-16,944
| -2% | -$2.76M | 6% | 2 |
|
|
2017
Q1 | $121M | Sell |
739,393
-9,019
| -1% | -$1.5M | 6.11% | 2 |
|
|
2016
Q4 | $109M | Sell |
748,412
-103,270
| -12% | -$15.5M | 5.55% | 5 |
|
|
2016
Q3 | $142M | Sell |
851,682
-52,713
| -6% | -$8.91M | 6.77% | 1 |
|
|
2016
Q2 | $138M | Sell |
904,395
-54,390
| -6% | -$8.46M | 6.46% | 2 |
|
|
2016
Q1 | $144M | Sell |
958,785
-110,183
| -10% | -$16.4M | 6.21% | 2 |
|
|
2015
Q4 | $142M | Buy |
1,068,968
+296,601
| +38% | +$46.6M | 6.34% | 1 |
|
|
2015
Q3 | $107M | Buy |
772,367
+275,197
| +55% | +$43.4M | 5.7% | 2 |
|
|
2015
Q2 | $76.3M | Buy |
497,170
+95,868
| +24% | +$15.4M | 4.98% | 5 |
|
|
2015
Q1 | $64.1M | Buy |
401,302
+64,281
| +19% | +$10.1M | 4.72% | 4 |
|
|
2014
Q4 | $53.7M | Sell |
337,021
-30,545
| -8% | -$4.76M | 4.95% | 5 |
|
|
2014
Q3 | $51.6M | Buy |
367,566
+8,529
| +2% | +$1.11M | 5.57% | 3 |
|
|
2014
Q2 | $42.5M | Buy |
359,037
+16,802
| +5% | +$1.94M | 4.63% | 7 |
|
|
2014
Q1 | $42.2M | Buy |
342,235
+42,696
| +14% | +$5.18M | 5.09% | 7 |
|
|
2013
Q4 | $34.2M | Buy |
299,539
+24,091
| +9% | +$2.74M | 4.71% | 8 |
|
|
2013
Q3 | $30.8M | Buy |
275,448
+41,850
| +18% | +$4.54M | 5% | 5 |
|
|
2013
Q2 | $23M | Buy |
+233,598
| New | +$24.2M | 4.67% | 7 |
|
Other funds holding AMGN
VCM
VPM
Smead Capital Management's AMGN Position: Q1 2026 in Review
Smead Capital Management reduced its Amgen (AMGN) stake by 13% in Q1 2026, selling an estimated $37M and leaving 697,919 shares worth $246M. The position accounts for 5.34% of the portfolio, ranked #5.
Smead Capital Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $378M in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Smead Capital Management held 697,919 shares of Amgen worth $246M as of Q1 2026.
- Smead Capital Management sold 103,877 Amgen shares in Q1 2026, an estimated $37M.
- Amgen made up 5.34% of Smead Capital Management's portfolio in Q1 2026, its #5 holding.
- Smead Capital Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Smead Capital Management's Amgen position peaked at $378M in Q3 2024.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Smead Capital Management's 13F filing for Q1 2026, filed 14 May 2026.